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Abstract Cognitive behaviour therapy (CBT) for young
people with obsessive compulsive disorder (OCD) has
become the treatment of first choice. However, the litera-
ture is largely based on studies emphasising exposure and
response prevention. In this study, we report on a ran-
domised controlled trial of CBT for young people carried
out in typical outpatient clinic conditions which focused on
cognitions. A randomised controlled trial compares 10
sessions of manualised cognitive behavioural treatment
with a 12-week waiting list for adolescents and children
with OCD. Assessors were blind to treatment allocation. 21
consecutive patients with OCD aged between 9 and
18 years were recruited. The group who received treatment
improved more than a comparison group who waited for
3 months. The second group was treated subsequently
using the same protocol and made similar gains. In con-
clusion, CBT can be delivered effectively to young people
with OCD in typical outpatient settings.
Keywords Obsessive compulsive disorder 
Cognitive behaviour therapy  Randomised controlled
trial  Treatment  Young people
Introduction
Obsessive compulsive disorder (OCD) is particularly a
severe and disabling psychological disorder. Recent epi-
demiological studies suggest that it affects around 1.9–
3.2% of the adult population and may have a 1-year
prevalence rate of up to 4% in late adolescence [13]. Fol-
low-up studies have shown that it has a chronic relapsing
course such that 50% of adult patients report their first
symptoms in childhood or adolescence and 50% of patients
with OCD in adolescence will continue to suffer disabling
effects from OCD in adulthood [2, 8, 35]. An effective
treatment for OCD in adolescence could offer significant
savings for the health service and improved quality of life
for many patients.
For adults, pharmacological treatments (selective sero-
tonin re-uptake inhibitors, SSRIs) have been shown to
reduce the level of symptomatology, but in up to 90% of
patients these gains are lost within 7 weeks of stopping
treatment [34]. The benefits of SSRIs for young people
with OCD have also been demonstrated (see [17] for a
meta-analysis), but there are concerns about the safety of
medication in young people on the grounds of both phys-
iology and risk taking behaviour. Although controversial,
these concerns impact on the acceptability of pharmaco-
therapy. In adults, it is known that SSRIs do not enhance
short-term adherence to psychological treatment, and in the
long term their use may impair the efficacy of psycholog-
ical treatments [15].
Recent expert consensus guidelines suggest that cog-
nitive behavioural treatments are the first choice treat-
ments for children and adolescents with OCD [21, 26]
although a Cochrane review concluded only that
‘‘behavioural or cognitive behaviour therapy (CBT)
appears to be a promising treatment for OCD in children
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and adolescents’’ [27]. Until recently, there have been few
trials which examine the effectiveness of cognitive
behavioural therapy for young people, based on the
assumption that adult-based research would generalise. In
general, controlled trials have demonstrated that CBT
techniques used for adults have generalised well [4, 6, 9,
11, 22]. The largest of these trials [22] demonstrated that
both medication and cognitive behavioural therapy were
effective treatments for OCD. However, there was a sig-
nificant site 9 treatment interaction such that in one site
CBT was significantly more effective than medication
whereas in the other site medication was found to be
more effective. Other controlled trials of CBT for young
people have found similar beneficial effects of CBT
compared with medication [4, 11].
The components of CBT for children have often been
poorly specified. Two components have been used by most
studies—exposure and response prevention (E/RP) and
anxiety management [4, 6, 9, 11, 22]. Bolton and Perrin [9]
have demonstrated that E/RP alone (with minimal anxiety
management) is sufficient to achieve significant benefits.
De Haan et al. [11] investigated the use of targeted cog-
nitive techniques including manipulating responsibility
cognitions demonstrating comparable effects for CBT and
medication. Two studies have delivered CBT in group
format [4, 6], without compromising the effect of CBT.
Furthermore, Barrett et al. [6] involved parents in treatment
with beneficial effects.
An alternative to managing anxiety around exposure and
response prevention is to target cognitions specific to OCD.
A number of candidate cognitive processes have been
suggested and a systematic review of cognitions related to
OCD symptoms in young people [28] suggested that three
models have some support: increased responsibility, meta-
cognitions, and thought–action fusion. These models are
difficult to distinguish empirically, because the processes
overlap. An appraisal of responsibility for intrusive
thoughts is a form of meta-cognition (thinking about
thoughts) and the appraisal that one’s thoughts might result
in actions or events occurring is of no significance unless
one appraises oneself as responsible for the thought. Evi-
dence for responsibility cognitions being specific to OCD
in adults has been provided by Salkovskis and his co-
workers [31] who demonstrated that they differentiate
patients with OCD from those with other emotional
disorders.
Studies with young people have not shown the clarity
of the link between responsibility and OCD expected
from the adult results [28]. Other aspects of cognition
such as thought–action fusion [7, 19, 23] and perfec-
tionism [19] are correlated with symptoms of OCD in
young people, although these relationships are substan-
tially mediated by responsibility cognitions [19, 24].
Reynolds and Reeves [28] point out, however, that the
relationships between these cognitive processes are
unclear and may be mediated or moderated by other
factors such as low mood. The robustness of the
responsibility cognitions model in adults and the evi-
dence that responsibility cognitions seem to be prob-
lematic in children with OCD suggest that there is utility
in examining the extent to which CBT which concen-
trated on responsibility cognitions could be used to treat
OCD.
Salkovskis and his colleagues [29] have developed a
package of cognitive behavioural treatment methods which
concentrates on responsibility cognitions. The components
that seem to be particularly important are:
1. normalising the nature of unpleasant intrusive
cognitions;
2. identifying the nature of the link between the thoughts
and the feelings of discomfort/anxiety and subsequent
neutralising rituals;
3. examining the logical nature of the links, and putting
them to the test by means of behavioural experiments;
4. comparing real danger with the worry about causing
harm, i.e. discriminating between thinking about and
acting upon;
5. helping the patient to identify that the effect of
attempting to control the thoughts leads to recurrence
of the thoughts or images;
6. helping the patient to consider alternative non-threat-
ening accounts of their obsessive problems.
The therapy also includes psychoeducation about anxi-
ety and an explanation of how trying to carry out exposure
and response prevention might seem difficult. Although
some exposure work was undertaken, it was always
explained in terms of finding out what happens to cogni-
tions and emotions. The therapists did not insist on waiting
until the uncomfortable feelings had subsided as is required
by exposure and response prevention. A pilot study [36] of
this form of CBT with young people suggested that the
changes in symptoms were paralleled by the changes in the
responsibility beliefs which initiate and maintain compul-
sive behaviours. The techniques also affect meta-cognition
in that they alter the beliefs about the nature and meaning
of cognitions associated with OCD. This form of CBT
differs from that used in the POTS trial [22] in its con-
centration on cognitions. The treatment does not aim to
teach the children to resist the impulse to carry out com-
pulsions, but rather to identify and change the miscon-
ceptions underlying the motivation to carry out
compulsions. A much larger study would be needed to test
this form of CBT against other forms of CBT or indeed a
purely behavioural treatment such as that in Bolton and
Perrin [9].
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Methods
Young people were recruited to the trial with a primary
diagnosis of OCD based on a semi-structured interview for
mental health problems (ADIS-C) [33]. In total, 21 young
people aged 9–18 years (mean age 13 years 7 months; 13
boys, 8 girls) were recruited from 22 cases referred by
Child and Adolescent Mental Health Teams or Family
Doctors for the trial (see Fig. 1 for CONSORT diagram).
Children were included if OCD was the major problem,
and it had been present for at least 6 months. Children were
excluded if they were unable to speak and understand
English fluently, if they had co-occurring psychosis or
autism spectrum disorder. At initial assessments, 11 pre-
sented with no other clinical diagnoses, while 4 received
diagnoses of generalised anxiety disorder, 4 specific
phobia, 4 separation anxiety, 2 ADHD, 2 social phobia, and
1 dysthymia. (The numbers do not add up to 10 because
only 2 had one additional diagnosis, the others having up to
three additional diagnoses.) Seven of the participants were
taking medication throughout the trial and had been taking
the same dose for 12 weeks prior to the trial (two on par-
oxetine 5 mg/day, three on fluoxetine 20 mg/day, one on
fluvoxamine 50 mg/day, one on clomipramine 50 mg/day).
There was no significant multivariate difference between
the treated group and the waiting list group at initial
assessment [F(6, 13) = 0.58, n.s.]. The therapists for the
trial (TW, HW, ST) were clinical psychologists employed
by the National Health Service (NHS) in England to work
in community child and adolescent mental health clinics.
All treatment took place in NHS clinics and was recorded
on audiotape if the young person consented.
Fig. 1 CONSORT diagram
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Procedure
Once consent was received for taking part in the trial, the
participants were allocated to either immediate treatment
(ten 1-h sessions) or a 12-week waiting list. Allocation was
carried out on a predetermined random number schedule
with no replacements by the trial administrator. Partici-
pants in the waiting list condition were informed that they
would have to wait 12 weeks for therapy, but they were
given the phone number of the lead clinician (TW) to
contact in the case of a significant deterioration in OCD.
Assessments were conducted at the beginning and end
of treatment (and/or waiting list period), and 12 weeks
after the end of treatment. All assessments were completed
in the child’s home unless specifically requested to be
elsewhere. Assessors were blind to the allocation of the
participants, and the participants were instructed not to
reveal whether they had received treatment. The assessors
completed two semi-structured interviews: Children’s
Yale-Brown Obsessive Compulsive Scale (C-YBOCS) [32]
to assess OCD symptoms, and the ADIS-C [33], a semi-
structured interview to assess the presence of other
comorbid disorders. Participant completed measures
included Child Depression Inventory [18], Obsessions and
Compulsions Inventory (OCI) [14] modified for children,
Multidimensional Anxiety Scale for Children [20], the
Children’s Responsibility Attributions Scale (CRAS), the
Children’s Responsibility Interpretations questionnaire
(CRIQ). Both the CRIQ and the CRAS are instruments
modified from the adult measures of responsibility cogni-
tions published in Salkovskis et al. [31]. The CRAS is
scored such that increasing score indicates a decreasing
level of responsibility attributions, whereas the other self-
report scales are scored such that increasing score indicates
increasing difficulties. An unpublished study by the first
author found that the internal reliability of the CRAS was
good in a large normative sample of 13–14-year olds
(Cronbach’s a = 0.85). The internal reliability in a sample
of young people with mental health problems for the other
scales was also high (OCI: Cronbach’s a = 0.93; RIQ
frequency: Cronbach’s a = 0.86; RIQ belief: Cronbach’s
a = 0.85). Copies of these measures are available on
http://psychology.iop.kcl.ac.uk/ocdkids/questionnaires/
questionnaires.aspx.
Treatments
Cognitive behaviour therapy was based on the principles
outlined by Salkovskis [29]. Participants worked with their
therapists to understand the cognitive distortions which
maintain their OCD. The aim of treatment is to alter
responsibility cognitions, primarily by doing experiments
both in session and at home. For instance, one common
belief encountered in OCD is that the sufferer is uniquely
responsible for harm occurring if certain rituals are not
carried out satisfactorily. The therapist and the participant
would agree during the session to carry out an experiment
designed to see what happens if responsibility is shared.
Another common task during therapy is to attempt to elicit
the worrying intrusive thoughts and examine whether they
have real meaning or are just thoughts. Treatment fidelity
was ensured through clinic notes, regular meetings of the
therapist team and audiotapes of treatment sessions.
Participants were allocated by the trial administrator to
the two groups using a table of random numbers. Only the
trial administrator was aware which participants were in
which group.
Results
Plan of analysis
The primary measure of OCD symptoms is the CYBOCS.
We first report an analysis of covariance of the CYBOCS
score at 3-month post-baseline assessment (with baseline
CYBOCS as the covariate), at which stage only one of the
two groups will have received an active treatment. This
analysis tests the hypothesis that there will be a group
effect at 3 months. We will then repeat the analysis of
covariance of the CYBOCS scores at 6-month post-base-
line when both groups will have received treatment. This
analysis tests the hypothesis that there will be a period by
group effect on the analysis of the CYBOCS scores at 3
and 6 months. Finally, we will analyse the secondary
measures (i.e. self-report data) in the same way using initial
values of the measure as the covariate.
Two clients dropped out of the study during the first
phase (one from each condition). In the following analyses,
the last observation was carried forward from the last
available observation. This is, therefore, an intention to
treat analysis.
Analysis of primary measure
Figure 2 shows the mean CYBOCS scores at baseline, 3
and 6 months. The analysis of covariance (baseline CY-
BOCS as covariate) of the CYBOCS at 3 months showed a
significant group effect [F(1) = 7.07, p = 0.016]. The
figure shows that this is due to a much improved CYBOCS
score for the group treated with CBT first. The group that
was allocated to the waiting list showed little or no
improvement over the same period. Cohen’s effect size (d)
for the difference between the two groups divided by the
mean standard deviation was calculated as 1.07, which is
considered to be a large treatment effect.
452 Eur Child Adolesc Psychiatry (2010) 19:449–456
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At 6 months, the analysis of covariance of CYBOCS
(using baseline CYBOCS as covariate) showed no group
effect as expected since both groups had received treat-
ment, although there was a trend towards a significant
effect of the covariate [F(1, 19) = 3.70, p = 0.07] sug-
gesting that the severity of OCD at the beginning of the
trial influences the outcome. As can be seen from Fig. 2,
both groups had improved significantly and the group that
was treated first showed continuing slight improvement.
Analysis of secondary measures
Analysis of the secondary data (the self-report question-
naires OCI, CRAS, CDI, CRIQ frequency, CRIQ belief;
see Table 1) used the same procedures, i.e. analysis of
covariance using the baseline value of the measure as the
covariate. There were no statistically significant group
effects at 3 months [OCI: F(1, 19) = 0.29, p = 0.59; CDI:
F(1, 19) = 0.49, p = 0.49; CRIQ frequency: F(1,
19) = 2.07, p = 0.17; CRIQ belief: F(1, 19) = 0.90,
p = 0.36; CRAS: F(1, 19) = 0.41, p = 0.53; MASC: F(1,
19) = 0.008, p = 0.929] but there were significant effects
of the covariate for each measure [OCI: F(1, 19) = 11.19,
p = 0.004; CDI: F(1, 19) = 12.20, p = 0.003; CRIQ fre-
quency: F(1, 19) = 13.06, p = 0.002; CRIQ belief: F(1,
19) = 17.26, p = 0.001; CRAS: F(1, 19) = 27.12,
p \ 0.001], except the MASC [F(1, 19 = 0.13, p = 0.72].
Inspection of Table 2 shows that the groups were
improving on all measures at the 3-month point.
A second analysis of covariance was carried out to
determine if the treatment was effective for both groups
using data from baseline and 6 months later after both
groups had received CBT. The results showed that there
was only a significant time effect [F(1, 19) = 53.14,
p \ 0.001] and no group [F(1, 19) = 0.06, p = 0.82] or
interaction effect [F(1, 19) = 0.73, p = 0.40]. As shown in
Fig. 1, the changes in CYBOCS are largest when the
groups are receiving treatment. Overall, the CYBOCS
scores of the participants reduced from 22.12 (SE = 1.08)
to 9.64 (SE = 1.79). Analysis of the secondary data also
showed significant changes from baseline to 6 months
[OCI: F(1, 19) = 18.35, p \ 0.001; CDI: F = 23.16,
p \ 0.001; RIQB: F(1, 19) = 32.8, p \ 0.001; RIQF: F(1,
19) = 25.15, p \ 0.001; RAS: F(1, 19) = 10.75,
p = 0.004; MASC: F(1, 19) = 22.81, p \ 0.001], but no
group effects [OCI: F(1, 19) = 0.45, p = 0.51; CDI: F(1,
19) = 0.53, p = 0.48; RIQB: F(1, 19) = 0.30, p = 0.59;
RIQF: F(1, 19) = 0.003, p = 0.38; RAS: F(1, 19) = 0.89,
p = 0.36; MASC: F(1, 19) = 0.30, p = 0.60] or interac-
tion effects [OCI: F(1, 19) = 1.41, p = 0.25; CDI: F(1,
19) = 0.42, p = 0.53; RIQB: F(1, 19) = 1.03, p = 0.32;
RIQF: F(1, 19) = 0.83, p = 0.38; RAS: F(1, 19) = 2.08,
p = 0.17; MASC: F(1, 19) = 0.27, p = 0.61]. Table 1
shows the means and standard deviations for all the
measures.
We followed the recommendations of Morris and
DeShon (2002 cited in [1]) to calculate the effect size as
the difference between the immediately pre-treatment
CYBOCS and the post-treatment CYBOCS divided by the
pre-treatment standard deviation (effect size = 2.62)
which also allows for the calculation of the effect size of
the waiting list. This effect size was compared with those
from other published trials which included a control group
(see Table 2). The results from this study fall within the
range of values reported heretofore.
Discussion
Cognitive behaviour therapy largely based on the use of
experiments to tackle the cognitive biases in OCD pro-
duced a significantly greater reduction in OCD symptoms
of the participants than a waiting list condition. Being
placed on the waiting list first did not affect the power of
the subsequent treatment. The self-report measures showed
a statistically significant reduction in self-reported symp-
toms over the two time periods but did not demonstrate an
effect of treatment. The study also shows only small
changes in symptoms for the young people placed on the
waiting list (cf. [1]), therefore confirming the chronic nat-
ure of OCD in young people. This adds to the body of
evidence in favour of CBT for OCD in young people. In
0
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Fig. 2 Mean CYBOCS scores for both groups at baseline, 3 and
6 months. Error bars represent standard errors of the mean at each
time point
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view of the potential problems associated with medication,
the results of this study support the view that young people
with OCD should, therefore, be offered CBT as the first-
line treatment by child and adolescent mental health
services.
This is the first randomised controlled study of a CBT
approach based on responsibility cognitions (following [29,
30]) with young people. Although the numbers treated in
this trial were small, the demonstration that the treatment
was as effective for the waiting list group demonstrates that
waiting for treatment had no effect on eventual outcome
and increases the power of the study. The 3-month follow-
up of the group that was treated first suggests that, at least
at first, the participants continued to improve after cessa-
tion of treatment.
The failure of the self-report measures to demonstrate a
difference between the groups at the 3-month point is
difficult to explain. Although a failure to find changes in
depression symptoms is not unusual in trials of CBT for
OCD [25], we had predicted a change in OCD symptoms
paralleling responsibility cognitions as was found in a pilot
study [36]. One possibility is that as found by Anholt et al.
[3] the changes in behaviour rather than the changes in
cognitions were the most significant feature of treatment.
However, it is also possible that the hope that someone else
was going to help with the problem improved the sub-
jective feelings tapped by self-report measures including
the appraisals of responsibility or affected the responsi-
bility cognitions directly (e.g. someone else is taking
charge of the OCD for me), but did not alter the assessor-
rated severity. If that is so, it might indicate that changing
cognitions alone are not sufficient to alter behaviour.
Indeed, the individual formulations of OCD used in this
treatment method use multiple maintenance cycles which
are described for each affected person. Yet another possi-
bility is that the self-report measures are not valid in this
population. Further research on the validity and reliability
of self-report measures would be helpful.
Other trials of CBT with young people have tended to
concentrate on managing the anxiety or discomfort expe-
rienced when undertaking exposure and response preven-
tion, e.g. [4, 6, 22]. The effect size observed in this trial is
somewhat less than those seen in previous trials of CBT for
young people with OCD (mean effect size 1.98, Table 3 in
[1]), although the differences in the methods of effect size
calculation make the comparison somewhat problematic.
Differences in the treatment offered may also be
important in determining the effectiveness of the inter-
vention. There are two lines of evidence: intra-trial site
differences and inter-trial differences. The POTS trial
compared CBT using E/RP and management of the distress
associated with OCD with a placebo medication condition
but found considerable site differences for both the CBT
and a third medication-only condition [22]. (Unfortunately
because the site data are only reported as Hedge’s g effect
sizes, we were unable to compare effect sizes using the
Morris and DeShon method [25] and calculated Hedge’s g
effect sizes in the following text.) The Hedge’s g effect size
for the POTS trial form of CBT varied from 0.51 in Chapel
Hill to 1.6 in Pennsylvania (a statistically significant
Table 1 Mean (SE) of self-report measures at baseline, 3 months (after first phase, one group treated) and 6 months (after second phase, both
groups treated)
Measure Baseline 3 months 6 months
CBT WL CBT WL CBT WL
CYBOCS 23.09 (1.22) 21.05 (1.84) 12.09 (2.25) 19.60 (2.03) 9.23 (2.45) 10.10 (2.74)
OCI 59.30 (8.28) 73.55 (8.26) 45.00 (8.30) 60.30 (9.62) 37.10 (8.73) 34.30 (5.51)
CDI 17.85 (2.76) 14.67 (1.82) 12.9 (2.62) 12.78 (2.92) 10.50 (2.41) 9.06 (2.56)
MASC 59.8 (6.87) 66.3 (6.74) 49.7 (5.90) 56.6 (6.69) 41.1 (4.40) 43.0 (7.28)
CRAS 49.00 (6.00) 51.00 (8.10) 58.00 (7.54) 63.63 (6.15) 58.00 (8.03) 74.13 (8.31)
CRIQ belief 634.38 (103.66) 781.11 (152.50) 563.13 (99.26) 537.78 (150.76) 320.63 (86.94) 332.22 (102.34)
CRIQ frequency 29.25 (4.31) 31.44 (5.14) 25.38 (3.90) 19.33 (5.45) 16.75 (4.36) 13.89 (4.35)
Gallop [16] reports means of 64.17 for CRAS (higher scores indicate less responsibility attributions), 451.7 for CRIQ belief and 17.4 for
frequency (where higher scores indicate more responsibility interpretations)
Table 2 Effect sizes on CYBOCS calculated according to Morris
and DeShon [25] for controlled studies of CBT in young people
Study Individual CBT
effect size
Waiting list or placebo
control effect size
This study -2.61792 -0.24914
March et al. [22] (placebo) -2.6087 -0.81818
De Haan et al. [11] -2.10169 N/A
Barrett et al. [6] -3.55349 0.198543
Negative numbers indicate improved CYBOCS scores. N/A indicates
that the study did not include a waiting list control
454 Eur Child Adolesc Psychiatry (2010) 19:449–456
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difference). The Hedge’s g effect size in this trial (1.07)
falls within that range. Bolton and Perrin [9] demonstrated
the benefits of E/RP alone compared with a wait list
(Hedge’s g effect size 1.23).
Our study does not provide information on the relative
merits of different forms of CBT. The difficulty with
attempting such a comparison is that the effect sizes of
different models of CBT appear to be comparable (see
previous paragraph). Of more interest in clinical practice
are issues such as the use of combinations of medication
and CBT and the involvement of the family. Studies with
adults have begun to show that offering medication first
diminishes the subsequent effectiveness of CBT [15].
Most of the studies on CBT with young people have
included the parents in treatment sessions, although Bolton
and Perrin [9] only provided feedback at the end of each
session. Recent work by Barrett et al. [6] showed that very
substantial reductions in OCD could be obtained by the use
of family management components in the treatment pack-
age. The families of young people with OCD differ in some
important respects from the families of young people with
anxiety disorders [5, 12]. Barrett’s study [5] demonstrated
that the parents were less confident in their child’s ability,
less rewarding of independence, and were less likely to use
positive problem solving than the parents of children with
anxiety disorders. Derisley et al. [12] found that parents
tended to use avoidant coping techniques as well as having
more symptoms of mental health problems. The NICE
guidelines too [26] suggest that the contribution of the
family to the treatment of young people with OCD needs
further investigation. However, the involvement of families
in the treatment of other emotional disorders in young
people has not always resulted in more improvement than a
less explicit component of family change [10]. Neverthe-
less, it would be worth investigating whether a family
component focused on problem-solving strategies and
developing confidence in the child’s abilities (based on
Barrett’s studies [5, 6]), and would be helpful in increasing
the effect of the CBT used in this study as has been par-
tially demonstrated by Barrett et al. [6].
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